Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients

Clinical trial NCT01563523 · COMPLETED

Trial details

NCT number: NCT01563523
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Trauma

Start date: 2002-03-01
Primary completion: 2003-10-01
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.